Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Therapeutic efficacy, animal models and experimental pharmacodynamics: what do we know about tigecycline?].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia - 1 Dec 2007

Giménez M J, Barberán J, Aguilar L

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Drug Resistance, Bacterial
Share to Gram-Negative Bacteria
Share to Gram-Positive Bacteria

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Microbial Sensitivity Tests

Share to Minocycline

Share to Models, Animal

Share to Tigecycline

Source

Identifiers

PMID: 18563212

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Therapeutic efficacy, animal models and experimental pharmacodynamics: what do we know about tigecycline?].PMID 18563212Read ↗

[New clinical evidence and drugs].Semantic proximity Read ↗

[Individualized drug therapy].Semantic proximity Read ↗

[PK/PD of antimicrobials].Semantic proximity Read ↗

Therapeutics: a glimpse of the future.Semantic proximity Read ↗

When good drugs go bad.Semantic proximity Read ↗

Tigecycline - how powerful is it in the fight against antibiotic-resistant bacteria?Semantic proximity Read ↗

[Quinolone].Semantic proximity Read ↗

New drugs.Semantic proximity Read ↗

The emergence of clinical resistance to tigecyclineSemantic proximity Read ↗

NSAIDs and Kelleni’s protocol as potential early COVID-19 treatment game changer: could it be the final countdown?Semantic proximity Read ↗

[Originality of entry inhibitors].Semantic proximity Read ↗

Risk factors analysis of hypofibrinogenemia associated with tigecyclineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.